A Novel Deletion within the Upstream Regulatory Region of Episomal Human Papillomavirus Type 16

References

1. Bankier A. T., Barrell B. G. 1983; Shotgun sequencing. Techniques in the life Sciences1–33 Flavell R. A. Limerick; Elsevier/North-Holland:
   [Google Scholar]
2. Bedell M. A., Jones K. H., Laimins L. A. 1987; The E6–E7 region of human papillomavirus type 18 is sufficient for transformation of NIH 3T3 and Rat-1 cells. Journal of Virology 61:3635–3640
   [Google Scholar]
3. Chin M. T., Hirochika R., Hirochika H., Broker T., Chow L. T. 1988; Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies. Journal of Virology 62:2994–3002
   [Google Scholar]
4. Choo K-B., Pan C-C., Han S-H. 1987; Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology 161:259–261
   [Google Scholar]
5. Cripe T. P., Haugen T. H., Turk J. P., Tabatabai F., Schmid P. G. III, Dürst M., Gissmann L., Roman A., Turek L. p. 1987; Transcriptional regulation of the human papillomavirus 16 E6–E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis. EMBO Journal 6:3745–3753
   [Google Scholar]
6. De Villiers E.-M., Wagner D., Schneider A., Miklaw H., Papendick U., Wagner D., Wesch H., Wahrendorf J., Zur Hausen H. 1987; Human papillomavirus infection in women with and without abnormal cervical cytology. Lancet ii:703–706
   [Google Scholar]
7. Dostatni N., Thierry F., Yaniv M. 1988; A dimer of BPV-1 E2 containing a protease resistant core interacts with its DNA target. EMBO Journal 7:3807–3816
   [Google Scholar]
8. Dürst M., Kleinheinz A., Hotz M., Gissmann L. 1985; The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. Journal of General Virology 66:1515–1522
   [Google Scholar]
9. Dürst M., Croce C. M., Gissmann L., Schwarz E., Huebner K. 1987; Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proceedings of the National Academy of Sciences U.S.A: 84:1070–1074
   [Google Scholar]
10. Gloss B., Bernard H. u., Seedorf K., Klock G. 1987; The upstream regulatory region of the human papillomavirus type 16 contains an E2 protein independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO Journal 6:3735–3743
    [Google Scholar]
11. Hirochika H., Hirochika R., Broker T. R., Chow L. T. 1988; Functional mapping of the human papillomavirus type 11 transcriptional enhancer and its interaction with the trans-acting E2 proteins. Genes and Development 2:54–67
    [Google Scholar]
12. Kanda T., Watanabe S., Yoshiike K. 1988; Immortalization of primary rat cells by human papillomavirus type 16 subgenomic DNA fragments controlled by the SV40 promoter. Virology 165:321–325
    [Google Scholar]
13. Lehn H., Villa L. L., Marziona F., Hilgarth M., Hillemans H.-G., Sauer G. 1988; Physical state and biological activity of human papillomavirus genomes in precancerous lesions of the female genital tract. Journal of General Virology 69:187–196
    [Google Scholar]
14. Moskaluk C. A., Bastia D. 1988; Interaction of the bovine papillomavirus type 1 E2 transcriptional control protein with the viral enhancer: purification of the DNA-binding domain and analysis of its contact points with DNA. Journal of Virology 62:1925–1931
    [Google Scholar]
15. Murdoch I. B., Cassidy L. J., Fletcher K., Cordiner J. W., Macnab J. C. M. 1988; Histological and cytological evidence of viral infection and human papillomavirus type 16 DNA sequences in cervical intraepithelial neoplasia and normal tissue in the west of Scotland: evaluation of treatment policy. British Medical Journal 296:381–385
    [Google Scholar]
16. Saiki R. K., Grelfand D. M., Stoffel S., Scharf S. J., Miguchi R., Horn G. T., Mullis K. B., Erlich H. A. 1988; Primer directed amplification of DNA with a thermostable DNA polymerase. Science 239:487–491
    [Google Scholar]
17. Sanger F., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences U.S.A: 74:5463–5467
    [Google Scholar]
18. Schneider-Maunoury S., Croissant O., Orth G. 1987; Integration of human papillomavirus type 16 DNA sequences: a possible early event in the progression of genital tumors. Journal of Virology 61:3295–3298
    [Google Scholar]
19. Seedorf K., Krämmer G., Dürst M., Suhai S., Röwekamp W. G. 1985; Human papillomavirus type 16 DNA sequence. Virology 145:181–185
    [Google Scholar]
20. Shirasawa H., Tomita Y., Kubota K., Kasai T., Sekiya S., Takamizawa M., Simizu B. 1988; Transcriptional differences of the human papillomavirus type 16 genome between precancerous lesions and invasive carcinomas. Journal of Virology 62:1022–1027
    [Google Scholar]
21. Smotkin D., Wettstein F. O. 1986; Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer derived cell line and identification of the E7 protein. Proceedings of the National Academy of Sciences, U.S.A 83:4680–4684
    [Google Scholar]
22. Southern E. M. 1975; Detection of specific sequences among DNA fragments separated by gel electrophoresis. Journal of Molecular Biology 98:503–517
    [Google Scholar]
23. Storey A., Pim D., Murray A., Osborn K., Banks L., Crawford L. 1988; Comparison of the in vitro transforming activities of human papillomavirus types. EMBO Journal 7:1815–1820
    [Google Scholar]
24. Thierry F., Yaniv M. 1987; The BPV1-E2 transacting protein can either be an activator or a repressor of HPV18 regulatory region. EMBO Journal 6:3391–3397
    [Google Scholar]
25. Vousden K. H., Doniger J., Dipaolo J. A., Lowyx D. R. 1988; The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene. Oncogene Research 3:167–175
    [Google Scholar]